>> aƷ >> Ʒˎ  
֪ՄtÿzIII“_tùίǰ׵Rо
lrg2018/6/14 17:51:35݋ahhuike g[Δ1662

       

         tÿzIII“_tùίǰ׵Rо
                       谡WԺtԺ671000


ժҪ Ŀ̽ίԷǼǰףCNP·utÿzIII“_tùίCNPįЧͰȫxȡԺί356CNPSCֱ߷֞ίMcսMÿM178л߾ڷ150mg_tùzbidίMҹgo1֧tÿz{ɽMߵίrg1ί󌦻M6SL^첢^ίǰcSLYɽMߵRYǰٰYu֣NIH-CPSIRЧͲYSLYίMNIH-CPSIuּu֣|uYuʹmu֣@ڌսMнyӋWxP0.05ίMЧʞ94.9%սM56.7%ίMЧ@ڌսMнyӋWxP0.001tÿz“_tùίǰcYϵăίԓЧˎԺȫɿֵRƏV
PI~ǰtÿz_tùЧ

The Clinical Study on Treatment of Prostatitis by BaoLieKangShu Medical Biological Dressing suppository Combined with Roxithromycin
YANG Ya-zhang   The First Affiliated Hospital of Dali University 671000
ABSTRACT Objective To explore a new method for the treatment of chronic nonbacterial prostatitis (CNP), and to evaluate the efficacy and safety of ZhenBaoKang medical antibacterial gel III combined with roxithromycin in the treatment of CNP. Methods 356 patients with CNP who were treated in our hospital were selected. Patients were divided into treatment group and control group according to the random number table method. There were 178 patients in each group. All patients were orally administered 150 mg roxithromycin capsules, bid. The treatment group at night to give a ZhenBaoKang medical antibacterial gel III anal. Two groups of patients were treated for 1 month, a total of one course of treatment. The patients were followed up for 6 months. The clinical symptoms, National Institutes of Health chronic prostatitis clinical symptom score index (NIH-CPSI), clinical efficacy and adverse reactions were observed and compared between the two groups before and after the follow-up. Results NIH-CPSI and the score (quality of life score, dysuria score, pain or discomfort score) of the treatment group were significantly lower than those of the control group at the end of follow-up, the difference was statistically significant (P<0.05). The effective rate was 94.9% in the treatment group and 56.7% in the control group. The effective rate of the treatment group was significantly higher than that of the control group (P<0.001). Conclusion ZhenBaoKang medical antibacterial gel III combined with roxithromycin in the treatment of chronic prostatitis is an excellent combination of external treatment and internal treatment. The method has high curative effect, convenient medicine, good tolerance, safe and reliable, Worthy of clinical application.
Key words: prostatitis; ZhenBaoKang medical antibacterial gel ; roxithromycin; efficacy

    ǰƳҊƼR^ߵİlԷǼǰףchronic non-bacterial prostatitisCNPзNǰ鳣Ҋsռǰײ90%CNPв^Lyc[1-2]оRίCNPxˎ䯟Ч@ˌҸЧίCNP·оxȡԺί356CNPtÿz“_tùMίȡ˝MįЧF
1 Yc
1.1 о xȡ2016420173gԺί356CNP\˜ʣߵ\2013AtWƌW֕CUAƶġǰ\ίָϡҎĘ˜[3]{˜ʣŻ߷\˜г^12ܵķ͹^ʹв̶ͬȵԹܺϵKƻǰװYe֣NIH-CPSI10ǰҺа׼10/HP֬wʧpǰٰĦҺ/Һ/ǰٰĦҺVB3Bǻg18qųǰֱcꎲ׃о@ԺίT֪ͬ߻Ҍپ֪ͬ
    SCֱSC֞ίMcսMÿM178ίMg28-65qƽ34.77.4q18-30ƽ21.65.9սMg32-68qƽ34.87.9q16-27ƽ21.36.2ɽMߵgcس̶ȱ^]нyӋWxP0.05пɱԣ1

1 ɽMߵĻRYϱ^
Ŀ ίM
n=178 սM
n=178 x2/t Pֵ
gsq 34.77.4 34.87.9 0.032 0.965
̣s£ 21.65.9 21.36.2 0.186 0.874
p[n%] 105.6 84.5 0.685 0.710
ж[n%] 3620.2 3218.0  
ض[n%] 13074.2 13877.5  

1.2 ί л߾ڷ150mg_tùzң@ˎIɷ޹˾a̖ˎH20103668ίbidίMҹgo1֧tÿz[ջտ﹤̼g޹˾a̖ʳˎOеʣ20142640025̖]{ɽMߵį̾1ί1
1.3 ^ָ ί󌦻M6SL^ίcSLYɽMߵRY^ɽMǰٰYu[National Institutes of Health Chronic Prostatitis Symptom IndexNIH-CPSI]|uYuʹmucu^ɽMߵRЧ
1.4 Чж oЧNIH-CPSIuֽͱ35%RYЧNIH-CPSIuֽͱ飨36-49%RY@ЧNIH-CPSIuֽͱ飨70-89%RYʧNIH-CPSIuֽͱ90%RYȫʧЧ=Ч+@Ч+ߔ/ߔ100%
1.5 yӋW SPSS21.0ܛMнyӋWӋYϲٷֱȱʾÿzMб^ӋYϲþֵ˜ʲʾtzMб^P0.05нyӋWx
2 Y
2.1 ίǰɽMNIH-CPSIuֱ^ ίǰɽMNIH-CPSIu|uYuʹmuֱ^oyӋWxP0.05SLYίMNIH-CPSIuּu@ڌսMнyӋWxP0.052@һYtÿz@CNPߵRY

2 ίǰcSLYɽMRY^
Ŀ ίǰ SLY
 ίM
n=178 սM
n=178 x2/t Pֵ ίM
n=178 սM
n=178 x2/t Pֵ
ʹmu֣s֣ 16.74.3 16.94.5 -0.216 0.849 5.70.6 7.91.0 -0.420 0.018
Yu֣s֣ 7.82.0 7.91.9 -0.248 0.824 2.90.5 4.21.1 -2.680 0.010
|u֣s֣ 10.21.8 9.91.7 0.533 0.615 10.21.8 9.91.7 -2.732 0.011
u֣s֣ 34.67.2 34.76.6 -0.066 0.959 12.43.3 17.62.8 -3.508 0.003

2.2 ɽM߯Ч^ SLYίMЧʞ94.9%սM56.7%ίMЧ@ڌսMнyӋWxP0.0013@һYʾtÿzίCNPЧ

3 SLYɽM߯Ч^
Ŀ ίM
n=178 սM
n=178 x2/t Pֵ
[n%] 2815.7 158.4 71.655 0.001
@Ч[n%] 3821.3 1910.7  
Ч[n%] 10357.9 6737.6  
oЧ[n%] 95.1 7743.3  
Ч[n%] 16994.9 10156.7 70.893 0.001

2.3 ɽM߲^ оYɽM߾δlصIJ

3 ӑՓ
    оǰհԇ򞷽utÿz“_tùίԷǼǰ׵RЧYSLYίMNIH-CPSIuּu@ڌսMP0.05ίMߵĿЧ@ڌսM94.9% vs. 56.7%P0.001@һYʾtÿzίԷǼǰׯЧõRǰ
    ǰڳжlijҊƼίԓкܶyί@ЩձίЧ^ɻ߼wӷߵĹɇصӰ[4-5]ĿǰֹԓIJ򲡙CҲδȫ
    tÿz麣ȻϺͼֲȡƄaƷÚWˎԭmጚЇˎƴWоJЏVVЧҰȫoԄӽǰװYλЧʹAȾоЧɷֿӼĤͨ͸տֲȡķwСǼg϶ʮ֮һԾտֲȡɸ͸^عܺǰٱĤֱǰٵװYӭhø5-֬øϩͨ|øĻĶ𵽿ךֹʹȾ߾ֲMͨ^̼CwϵyCwͲȾĵֿ_粡MMޏcĹЧ
    FtWоֱc܇SĄ}o}ֱܰͅcճĤк܏չֱcoˎ;Tcڽoˎ^θСcAøˎӰ푺ƉҲͬrppˎθcĴ̼˘Oˎö[6]ǰپoֱcֱcoˎʹˎֱ_ίǰټЧ[7-11]ͬrtÿzίCNP˷Lڷÿˎ߸KΣˎԌwēpһNdzȫǰίˎ
    Ŀǰǰ׵ҪίMпί_tùǴh֬ˎԓˎ÷ʸԺ;΢Ե50Swλ໥YM䵰|ĺϳԓ^кĺϳɲδܵӰǰײsвȸȾ߀񽛼ȪMխ߼ǰٹ܃ȷÿy_M⯟Ч[12-15]˱оc“ίķ@˯Ч˰Y
    Ctÿz“_tùίǰcYϵķȡõįЧͬrˎԺȫɿֵRƏV

īI
[1] ɽ, A, a, . Լǰ׵ίоMչ[J]. tˎ,   2014, 20(13): 65-68.
[2] ƺ, T. ԷǼǰ׵ί[J].ɽtˎs־, 2016, 45(8): 914-916. 
[3] PĿ̌W܊.пtáCUAǰ\ίָϡ\CPPS{[J].AпƌWs־2013,192127-131.
[4]Qin Z, Zang Z, Wu J, et al. Efficacy of acupuncture for chronic prostatitis/chronic pelvic pain syndromes: study protocol for a randomized, sham acupuncture-controlled trial[J]. BMC Complement Altern Med, 2016,16(1):440.
[5] , , R, . ǰcǰPϵR[J].tWՓc`, 2016, 29(1):75-76. 
[6] \P. ֱcoˎƄđMչ[J].ЇtԺˎWs־, 2013,33(23) :1969- 1971.
[7] 袱܊, ţ. ˎֱcoˎίǰЧȫur[J]. t, 2014,46(8):71- 73.
[8] SӢ, ׌W. ̩z“_tùؾzίǰ229[J]. Itˎ, 2011, 31(3) :177.
[9] Holt JD, Garrett WA, McCurry TK, et al. Common Questions About Chronic Prostatitis[J]. Am Fam Physician, 2016, 93(4):290-296.
[10] , wڐ. t“ίǰ[J].Їtˎָ, 2014, 6(1) :112-113.
[11] Moayednia A, Haghdani S, Khosrawi S, et al. Long-term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis [J]. J Res Med Sci, 2014,19(4):293-296.
[12] , , Ѧ.ˎЧɷίǰ׵ߙC[J].AпƌWs־,2016,22(1):63-66. 
[13]S~,wym,.ᘾČǰםCSIgAӰ[J].FtYs־,2015,24(03):288-290.
[14]x\,x,,׿.sȪz“ˎίI̝̓ǰR^[J].Ϻtˎs־,2014,48(07):47-49.
[15].tYίǰ55[J].ʝtWƌWУW,2014,26(01):39-40.

һƪ ʡtW^mv--ѩɽnjtßNw
һƪ ףR2018}пƌWm˼gƏVh_
P]
ջտ﹤̼g޹˾ © 2009 - 2019 AHHUIKE Inc.ICP09010236̖
“WˎƷϢYC̖-ǽI-2019-0019
˾aַʡ̫Ϳh_l^A^ Ԓ05588215588 棺05588696288
pkʰĿ ʮһѡ© Ӿ̳ͼٱ ɹſ3ƼɹŸʿԤ ɹŸʿ淨 pk10 Ͽʮ淨 ֳŲ ϿСͼ ʿ12ͼ Dzôн